Evidence map›Paper›PMID 32572754›Full record

ArticleJournal of robotic surgery2021

Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.

Andrew D Supron, Joseph G Cheaib, Michael J Biles, Zeyad Schwen, Mohamad Allaf, Phillip M Pierorazio

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andrew D SupronJohns Hopkins University School of Medicine, Baltimore, MD, USA. Asupron1@jhmi.edu.ORCID http://orcid.org/0000-0003-0936-4989
Joseph G CheaibThe James Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Michael J BilesThe James Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Zeyad SchwenThe James Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Mohamad AllafThe James Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Phillip M PierorazioThe James Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objectives were to evaluate the safety and oncologic efficacy of primary robotic retroperitoneal lymph node (R-RPLND) dissection for testicular germ cell tumors. A retrospective analysis was performed on all primary R-RPLND cases performed by a single surgeon, who performs both open and R-RPLND at a high-volume academic institution, between August 2013 and August 2019. Data on patient demographics, operative techniques, perioperative outcomes, and tumor characteristics were obtained. 28 men were identified who underwent primary R-RPLND. The majority of patients (N = 21, 75%) had clinical stage I disease, and a bilateral template was more commonly performed than either single side alone (N = 13, 46%). Of note, two cases involving clinical stage II disease were converted electively from robotic to open procedures at the discretion of the surgeon. R-RPLND patients experienced no intraoperative complications. The median follow-up time was 8 months (interquartile range 4-29 months). One (4%) patient developed a disease recurrence at 10 months after R-RPLND. Conclusion: primary R-RPLND is a safe and efficacious procedure for carefully selected men with stage I and II non-seminomatous germ cell tumors of the testis. Long-term data are needed to evaluate the comparative oncologic efficacy with open surgery and the notably high rate of chylous ascites.

Indexed as

AgedFollow-Up StudiesHumansLymph Node ExcisionMaleMiddle AgedNeoplasms, Germ Cell and EmbryonalNeoplasm StagingOrchiectomyRetrospective StudiesRobotic Surgical ProceduresSafetyTesticular NeoplasmsTreatment OutcomeRetroperitoneal lymph node dissectionRobotic urologyTesticular cancerUrology

Identifiers

PMID32572754
OpenAlexW3035794589

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.